Retrievable Stents Market to Expand at 6.2% CAGR Through 2031, Driven by Rising Acute Stroke and Neurovascular Interventions | DataM Intelligence

The global retrievable stents market is projected to grow at a CAGR of 6.2% during the forecast period 2024-2031, driven by the rising prevalence of acute ischemic stroke, increasing adoption of minimally invasive neurovascular procedures, and continuous advancements in stent retrievability and thrombectomy technologies. Growing investments in stroke care infrastructure and rapid expansion of neurointerventional capabilities are further supporting market growth.

Get a Free Sample PDF of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/retrievable-stents-market?jd

North America - Key Industry Developments
✅ January 2026: Medtronic Plc expanded its neurovascular product portfolio in the U.S., strengthening its retrievable stent offerings for acute ischemic stroke treatment across comprehensive stroke centers.
✅ December 2025: Boston Scientific Corporation increased investments in next-generation thrombectomy and retrievable stent technologies to support faster clot retrieval and improved patient outcomes.
✅ December 2025: U.S.-based hospitals accelerated adoption of advanced retrievable stents following updated stroke treatment protocols emphasizing rapid mechanical thrombectomy.

Asia-Pacific - Key Industry Developments
✅ January 2026: Lepu Medical expanded its neurointerventional device manufacturing capacity in China to meet growing demand for retrievable stents across regional stroke centers.
✅ December 2025: Meril Life Sciences Pvt. Ltd. strengthened its distribution network across Southeast Asia to support wider access to cost-effective retrievable stents.
✅ December 2025: Regional healthcare systems in India and China increased investments in stroke care units, boosting demand for advanced neurovascular devices including retrievable stents.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=retrievable-stents-market
(Purchase 2 or more Reports and get 50% Discount)

Key Mergers and Acquisitions
✅ December 2025: Boston Scientific Corporation entered strategic discussions to acquire a specialized neurovascular device startup to enhance its retrievable stent and thrombectomy portfolio.
✅ January 2026: Medtronic Plc explored collaborative agreements with Asia-based medical device manufacturers to strengthen supply chain resilience and regional market penetration.

Market Segmentation Analysis
• By Type: Partially Recoverable, Completely Recoverable. Completely recoverable stents dominate due to higher procedural safety and flexibility during thrombectomy procedures.
• By Indication: Acute Stroke, Cerebral Aneurysms, Intracranial Aneurysms, Acute Intracranial Atherosclerotic Stenosis, Intracranial Vascular Disease, Others. Acute stroke remains the leading indication, supported by rising incidence rates and faster diagnosis.
• By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics. Hospitals account for the largest share due to advanced neurointerventional infrastructure.

Regional Insights
North America holds the largest share of the retrievable stents market, supported by high stroke awareness, advanced healthcare infrastructure, favorable reimbursement policies, and strong presence of global device manufacturers.
Asia-Pacific is the fastest-growing region, driven by rising stroke burden, improving healthcare access, expanding neurointerventional capabilities, and increasing adoption of minimally invasive treatments across emerging economies.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/retrievable-stents-market?jd

Growth Drivers
1. Rising global prevalence of acute ischemic stroke and neurovascular disorders.
2. Increasing adoption of minimally invasive thrombectomy procedures.
3. Technological advancements in retrievable stent design and materials.
4. Expanding stroke care infrastructure in emerging economies.
5. Strategic collaborations and product innovations by key market players.

Key Players:
The major global players in the retrievable stents market include NeuroSafe Medical Co., Ltd., Stron Medical, Boston Scientific Corporation, Allium Medical, Medtronic Plc, Meril Life Sciences Pvt. Ltd., Translumina Therapeutics, and Lepu Medical, among others.

Key Highlights (Top 5 Key Players):
1. Medtronic Plc leads with advanced neurovascular and thrombectomy solutions globally.
2. Boston Scientific Corporation focuses on next-generation retrievable stents for improved stroke outcomes.
3. Lepu Medical strengthens its presence across Asia-Pacific with expanding manufacturing capacity.
4. Meril Life Sciences Pvt. Ltd. delivers cost-effective neurovascular solutions in emerging markets.
5. Translumina Therapeutics supports growing adoption through innovative interventional device offerings.

Unlock 360° Market Intelligence with DataM Intelligence Subscription Services:
https://www.datamintelligence.com/reports-subscription?jd
✅ Competitive Landscape Analysis
✅ Company Profile Analysis
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updates
✅ Live Market & Pricing Trends
✅ Regulatory and Supply-Chain Analysis

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.